| Product Code: ETC5293447 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Ireland Nuclear Medicine Market may undergo a gradual slowdown in growth rates between 2025 and 2029. Beginning strongly at 11.47% in 2025, growth softens to -6.26% in 2029.

The Nuclear Medicine market in Ireland is projected to grow at a stable growth rate of 3.12% by 2027, highlighting the country's increasing focus on advanced technologies within the Europe region, where Germany holds the dominant position, followed closely by United Kingdom, France, Italy and Russia, shaping overall regional demand.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Nuclear Medicine Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Nuclear Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Nuclear Medicine Market - Industry Life Cycle |
3.4 Ireland Nuclear Medicine Market - Porter's Five Forces |
3.5 Ireland Nuclear Medicine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Nuclear Medicine Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Ireland Nuclear Medicine Market Revenues & Volume Share, By Volume Assessment, 2021 & 2031F |
4 Ireland Nuclear Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and cardiovascular diseases in Ireland, driving the demand for nuclear medicine diagnostics and treatments. |
4.2.2 Technological advancements in nuclear medicine imaging techniques, improving accuracy and efficiency. |
4.2.3 Growing investments in healthcare infrastructure and facilities in Ireland, enhancing the accessibility of nuclear medicine services. |
4.3 Market Restraints |
4.3.1 High initial setup costs and ongoing maintenance expenses associated with nuclear medicine equipment. |
4.3.2 Stringent regulatory requirements and safety concerns related to radioactive materials used in nuclear medicine procedures. |
4.3.3 Limited availability of skilled professionals and specialists in the field of nuclear medicine in Ireland. |
5 Ireland Nuclear Medicine Market Trends |
6 Ireland Nuclear Medicine Market Segmentations |
6.1 Ireland Nuclear Medicine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Nuclear Medicine Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2021-2031F |
6.1.3 Ireland Nuclear Medicine Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2021-2031F |
6.1.4 Ireland Nuclear Medicine Market Revenues & Volume, By Brachytherapy Isotopes, 2021-2031F |
6.2 Ireland Nuclear Medicine Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Ireland Nuclear Medicine Market Revenues & Volume, By Diagnostic Applications, 2021-2031F |
6.3 Ireland Nuclear Medicine Market, By Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Ireland Nuclear Medicine Market Revenues & Volume, By Diagnostic Procedures, 2021-2031F |
6.3.3 Ireland Nuclear Medicine Market Revenues & Volume, By Therapeutic Procedures, 2021-2031F |
7 Ireland Nuclear Medicine Market Import-Export Trade Statistics |
7.1 Ireland Nuclear Medicine Market Export to Major Countries |
7.2 Ireland Nuclear Medicine Market Imports from Major Countries |
8 Ireland Nuclear Medicine Market Key Performance Indicators |
8.1 Patient wait times for nuclear medicine procedures, indicating efficiency and accessibility of services. |
8.2 Adoption rate of new nuclear medicine technologies and techniques, reflecting market acceptance and technological advancements. |
8.3 Number of research collaborations and clinical trials in nuclear medicine within Ireland, showcasing innovation and industry growth. |
9 Ireland Nuclear Medicine Market - Opportunity Assessment |
9.1 Ireland Nuclear Medicine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Nuclear Medicine Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Ireland Nuclear Medicine Market Opportunity Assessment, By Volume Assessment, 2021 & 2031F |
10 Ireland Nuclear Medicine Market - Competitive Landscape |
10.1 Ireland Nuclear Medicine Market Revenue Share, By Companies, 2024 |
10.2 Ireland Nuclear Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here